New Delhi [India], March 1 (ANI): Prime Minister Narendra Modi undergoing COVID-19 vaccination will go a long way in getting over vaccine hesitancy in the country, said All India Institute of Medical Sciences (AIIMS) Delhi Director Dr Randeep Guleria on Monday.
Kolkata (West Bengal) [India], February 24 (ANI): AIIMS Delhi Director Dr Randeep Guleria on Wednesday termed the government's move to vaccinate people above 60 years and above 45 years with comorbidities "as a very good step" and the move to expand the vaccination ambit will also help in
Kolkata (West Bengal) [India], February 24 (ANI): Sero surveillance data has shown that only around 20 to 25 per cent of individuals across the country have positive antibodies, so herd immunity by natural infection is very difficult to achieve, according to All India Institute of Medical Sc
New Delhi [India], February 24 (ANI): With two new strains of Covid-19, one each from the UK and Brazil, confirmed in a number of states, AIIMS Director Randeep Guleria on Wednesday said that vaccines will be able to control the spread of coronavirus and lessen the mortality rate.
New Delhi [India], February 17 (ANI): Coronavirus vaccines might be available in the open market by end of the year only when prime targeted people are covered and there is an equivalence of supply and demand, said Dr. Randeep Guleria, Director of All India Institute of Medical Sciences (
New Delhi [India], January 16 (ANI): AIIMS Director Dr Randeep Singh Guleria and NITI Aayog member VK Paul on Saturday were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of nationwide roll-out of vaccination.
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Singh Guleria today lauded the work done by Indian laboratories in making indigenous vaccines.
New Delhi [India], January 3 (ANI): As India gears up for the world's largest vaccination programme, the Ministry of Health and Family Welfare addressed apprehensions expressed by the public regarding the COVID-19 vaccine's effectiveness, safety and availability, among others.
New Delhi [India], January 3 (ANI): With vaccine roll out on the cards after Drugs Controller General of India's (DCGI) approval, the country needs to tackle public and administrative challenges to have a smooth vaccination roll-out, said Randeep Guleria, Director, All India Institute of Med
New Delhi [India], January 1 (ANI): BJP president Jagat Prakash Nadda on Friday informed that he and his family members have fully recovered from COVID-19, thanking AIIMS director Randeep Guleria and his team for their dedication and support.
New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.